Bavarian Biotech Report 2011/2012 (7MB) - Bio M

PAN Biotech GmbHBIOTECH DEVICES & REAGENTSContact:Prof. Dr. Michael WiechmannGewerbepark 13D-94501 AidenbachPhone: +49 (0) 8543 601630Fax: +49 (0) 8543 601649E-Mail: info@pan-biotech.deInternet: www.pan-biotech.dePAN-Biotech GmbH is a modern and innovative company with its headquartersin Aidenbach/Germany.PAN-Biotech was founded in 1988 and is today a major producer of biotechnologicalproducts which are worldwide distributed and used in researchand industry.The product range includes new serum- and proteinfree media, sera (FCS)from different countries of origin including important special variants and abroad variety of media for cell culture. Important new product areas are ourautomated cell culture systems for research and industry as well as new servicesall around the cell culture and cell processing.As a specialist for cell culture we can offer you nearly the complete range ofproducts and services that you need for your successful cell culture.Contact:Michael HahnLochhamer Schlag 21D-82166 GräfelfingPhone: +49 (0) 89 742846-831Fax: +49 (0) 8151 279-6331E-Mail: m.hahn@pari.deInternet: www.paripharma.comPARI Pharma GmbHPHARMA & CHEMICAL INDUSTRY, MEDTECHKeywords: Drug Development, Drug Delivery, Analytical Chemistry,Liposomes, Antibiotics, Infectious Diseases, Respiratory DiseasesPARI Pharma focuses on the development of aerosol delivery devices andcomprehensive inhalation drug development to advance aerosol therapieswhere drug and device can be optimized together. Based on PARI’s 100-yearhistory working with aerosols, PARI Pharma develops treatments forpulmonary and nasal administration customized with advanced deliveryplatforms, such as eFlow (lower respiratory) and Vibrent (upper respiratory)Technologies. PARI Pharma partners with pharmaceutical companies todevelop new or improved therapies. PARI Pharma has several clinicaldevelopment programs ongoing, either partnered or on its own, for cysticfibrosis, asthma, COPD, respiratory syncytial virus (RSV) infection, andtreatments for lung transplant patients among other indications. PARIPharma, a PARI Medical Holding company, is located near Munich, Germanywith a major presence in the United States.98